☰

Shaun D. Fouse, Ph.D. - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, Choi S, Hong C, He D, Pekmezci M, Wiencke JK, Wrensch MR, Chang SM, Walsh KM, Myong S, et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science (New York, N.Y.). 348: 1036-9. PMID 25977370 DOI: 10.1126/Science.Aab0015  0.338
2015 van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, et al. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathologica. 129: 597-607. PMID 25724300 DOI: 10.1007/S00401-015-1403-6  0.542
2015 Fouse SD, Steino A, Butowski N, Bacha JA, Kanekal S, Santos ND, Costello JF, Brown DM. Abstract B28: Dianhydrogalactitol inhibits the growth of glioblastoma multiforme stem and non-stem cultures, in vitro and in vivo Brain. 75. DOI: 10.1158/1538-7445.Brain15-B28  0.343
2015 Fouse SD, Steino A, Butowski N, Bacha JA, Kanekal S, Santos ND, Brown DM, Costello JF. Abstract 2562: Dianhydrogalactitol inhibits the growth of glioma stem and non-stem cultures, including temozolomide-resistant cell lines, in vitro and in vivo Cancer Research. 75: 2562-2562. DOI: 10.1158/1538-7445.Am2015-2562  0.404
2015 Bell R, Rube HT, Kreig A, Mancini A, Fouse S, Nagarajan R, Choi S, Hong C, He D, Pekmezci M, Wiencke J, Wrensch M, Chang S, Walsh K, Myong S, et al. GENO-07A MECHANISM OF MUTANT TERT PROMOTER ACTIVATION SHARED ACROSS CANCER TYPES Neuro-Oncology. 17: v92.3-v92. DOI: 10.1093/Neuonc/Nov215.07  0.394
2014 Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen AB, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF. Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Research. 24: 761-74. PMID 24709822 DOI: 10.1101/Gr.164707.113  0.582
2014 Fouse SD, Nakamura JL, James CD, Chang S, Costello JF. Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype. Neuro-Oncology. 16: 361-71. PMID 24311636 DOI: 10.1093/Neuonc/Not223  0.38
2014 Fouse S, Steino A, Butowski N, Bacha J, Brown D, Costello J. ET-18 * VAL-083 IS A NOVEL N7 ALKYLATING AGENT THAT INHIBITS THE GROWTH OF GLIOMA STEM AND NON-STEM CULTURES, INCLUDING TEMOZOLOMIDE-RESISTANT LINES Neuro-Oncology. 16: v83-v83. DOI: 10.1093/Neuonc/Nou255.18  0.429
2013 Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, Bloch O, Ivan ME, Kaur R, Oh T, Fouse SD, Phillips JJ, Berger MS, Parsa AT. Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro-Oncology. 15: 1518-31. PMID 23887941 DOI: 10.1093/Neuonc/Not099  0.328
2013 Fouse SD, Costello JF. Cancer Stem Cells Activate STAT3 the EZ Way. Cancer Cell. 23: 711-3. PMID 23763996 DOI: 10.1016/J.Ccr.2013.05.016  0.418
2013 Nagarajan RP, Fouse SD, Bell RJ, Costello JF. Methods for cancer epigenome analysis. Advances in Experimental Medicine and Biology. 754: 313-38. PMID 22956508 DOI: 10.1007/978-1-4419-9967-2_15  0.451
2012 Craig JM, Vena N, Ramkissoon S, Idbaih A, Fouse SD, Ozek M, Sav A, Hill DA, Margraf LR, Eberhart CG, Kieran MW, Norden AD, Wen PY, Loda M, Santagata S, et al. DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues. Plos One. 7: e38881. PMID 22719973 DOI: 10.1371/Journal.Pone.0038881  0.379
2011 Fouse SD, Nagarajan RP, Nakamura J, James CD, Chang S, Costello JF. Abstract B44: Therapeutic response of primary glioblastoma cancer stem cells relative to patient-matched non-stem tumor cells Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-B44  0.427
2010 Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nature Biotechnology. 28: 1097-105. PMID 20852635 DOI: 10.1038/Nbt.1682  0.502
2010 Fouse SD, Nagarajan RO, Costello JF. Genome-scale DNA methylation analysis. Epigenomics. 2: 105-17. PMID 20657796 DOI: 10.2217/Epi.09.35  0.517
2010 Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 466: 253-7. PMID 20613842 DOI: 10.1038/Nature09165  0.634
2010 Fouse SD, Robert B, Downey S, Nakamura J, Chang S, Costello JF. Abstract B38: Therapeutic response in primary glioblastoma neural stem cells relative to patient-matched non-stem tumor cells Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-B38  0.362
2009 Fouse SD, Costello JF. Epigenetics of neurological cancers. Future Oncology (London, England). 5: 1615-29. PMID 20001799 DOI: 10.2217/Fon.09.132  0.578
2009 Shen Y, Fouse SD, Fan G. Genome-wide DNA methylation profiling: the mDIP-chip technology. Methods in Molecular Biology (Clifton, N.J.). 568: 203-16. PMID 19582429 DOI: 10.1007/978-1-59745-280-9_13  0.692
2008 Fouse SD, Shen Y, Pellegrini M, Cole S, Meissner A, Van Neste L, Jaenisch R, Fan G. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell. 2: 160-9. PMID 18371437 DOI: 10.1016/J.Stem.2007.12.011  0.722
2008 Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proceedings of the National Academy of Sciences of the United States of America. 105: 4709-14. PMID 18339804 DOI: 10.1073/Pnas.0712018105  0.569
2007 Feng J, Fouse S, Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatric Research. 61: 58R-63R. PMID 17413844 DOI: 10.1203/Pdr.0B013E3180457635  0.711
2005 Fan G, Martinowich K, Chin MH, He F, Fouse SD, Hutnick L, Hattori D, Ge W, Shen Y, Wu H, ten Hoeve J, Shuai K, Sun YE. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development (Cambridge, England). 132: 3345-56. PMID 16014513 DOI: 10.1242/Dev.01912  0.554
2003 Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (New York, N.Y.). 302: 890-3. PMID 14593184 DOI: 10.1126/Science.1090842  0.689
Show low-probability matches.